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Environmental factors, particularly fungi, influence the pathogenesis of allergic airway
inflammation, but the mechanisms underlying these effects are still unclear. Melanin is one
fungal component which is thought to modulate pulmonary inflammation. We recently
identified a novel C-type lectin receptor, MelLec (Clec1a), which recognizes fungal 1,8-
dihydroxynaphthalene (DHN)-melanin and is able to regulate inflammatory responses.
Here we show that MelLec promotes pulmonary allergic inflammation and drives the
development of Th17 T-cells in response to spores of Aspergillus fumigatus.
Unexpectedly, we found that MelLec deficiency was protective, with MelLec-/- animals
showing normal weight gain and significantly reduced pulmonary inflammation in our
allergic model. The lungs of treated MelLec-/- mice displayed significantly reduced
inflammatory foci and reduced bronchial wall thickening, which correlated with a
reduced cellular influx (particularly neutrophils and inflammatory monocytes) and levels
of inflammatory cytokines and chemokines. Notably, fungal burdens were increased in
MelLec-/- animals, without apparent adverse effects, and there were no alterations in the
survival of these mice. Characterization of the pulmonary T-cell populations, revealed a
significant reduction in Th17 cells, and no alterations in Th2, Th1 or Treg cells. Thus, our
data reveal that while MelLec is required to control pulmonary fungal burden, the
inflammatory responses mediated by this receptor negatively impact the animal welfare
in this allergic model.
Keywords: C-type lectin, asthma, Aspergillus fumigatus, MelLec, allergyAbbreviations: MelLec, melanin-sensing C-type lectin receptor; DHN melanin, 1,8-dihydroxynaphthalene melanin; wt,
wild-type.
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Fungi have an enormous, but largely unrecognized, impact on
human morbidity and mortality including allergic airway
disease, for which fungal sensitization is increasingly being
realized to play a major role in disease pathology (1). There is
compelling evidence that fungi are associated with the
development and severity of asthma, in particular, and several
studies have demonstrated the beneficial effects of antifungal
therapy on disease progression (2). Common fungal species
associated with sensitization include spp. of Alternaria,
Cladosporium and Aspergillus which all possess allergens,
including fungal cell wall components, that are recognized by
pattern recognition receptors such as those of the C-type lectin
receptor (CLR) family (3). CLRs and their downstream signaling
pathways play critical roles in mediating innate and adaptive
anti-fungal immune responses (4). Moreover, several of these
receptors have been implicated in asthma pathogenesis (3, 5).
We recently identified a novel fungal-sensing CLR, MelLec,
which recognizes DHN-melanin, a non-carbohydrate cell wall
component found in many asthma-associated fungal species,
including species of Aspergillus fumigatus (6). MelLec is
ubiquitously expressed by CD31+ endothelial cells in mice, and
is also expressed by a small sub-population of these cells that co-
express epithelial cell adhesion molecule (EpCAM) that are
detected only in the lung and the liver (6). In humans, MelLec
is also expressed on myeloid cells (7). We found MelLec to play
an essential role during invasive infection with this pathogen in
both mice and humans (6), that the receptor is involved in the
regulation of early pulmonary inflammatory responses following
intratracheal challenge of immunocompetent MelLec-deficient
mice with a single bolus of A. fumigatus conidia (6). Given the
impact of MelLec on pulmonary responses, we explored here the
contribution of this CLR to the development of allergic airway
inflammation in response to A. fumigatus using a murine model.MATERIALS AND METHODS
Mice
8–10 week old wild type (wt) C57BL/6 and MelLec-/- mice (6)
were bred and maintained in the specific pathogen-free facilities
of the University of Aberdeen. wt and MelLec-/- animals were co-
housed for 2-weeks prior to experimentation and randomly
assigned to experimental and control groups. Experiments
were not blinded. All animal use was approved and in
compliance with local University animal research ethical
regulations and a UK Home Office project l icence
(P79B6F297). Mice were sacrificed by Pentobarbital sodium
(Euthatal®). The physical condition of the animals was
checked at least once daily.
Airway Challenges
Aspergillus fumigatus ATCC 13073 was cultured on potato
dextrose agar plates at 37°C for 7 days and the conidia
resuspended in 0.1% of Tween 80, filtered with a 40mm cellFrontiers in Immunology | www.frontiersin.org 2strainer to remove mycelia and washed twice in PBS. In all
experiments, mice were anesthetized with an intraperitoneal
administration of 76 mg/g body weight of ketamine
(Narketan®) and 1 mg/g body weight of medetomidine
(Domitor®). Mice were sensitized intratracheally (non-surgical)
on days 0, 7 and challenged on days 20, 21, and 22 with
Aspergillus fumigatus ATCC 13073 conidia at 1x107 in 40 ml of
PBS, as per previously established models (5). Mice were roused
with an intraperitoneal administration of 1mg/g body weight of
atipamezole (Antisedan®). Mice were sacrificed on day 23, 24 hrs
after the last-challenge with A. fumigatus (Figure 1). The right
lung was used for flow cytometry and the left lung was used
for cytokine assays or fungal burdens. A. fumigatus conidia
were heat-killed at 65°C for 1hr for the data presented in
Supplementary Figure 3.Flow Cytometry
Flow cytometry was performed using standard methodology. In
brief, lungs were digested with the lung dissociation kit (Miltenyi
Biotec GmbH, Germany) and dispersed using GentleMACS
(Miltenyi Biotec GmbH, Germany), and then passed through a
70 mm strainer to obtain single cell suspensions. Cells were
recovered by centrifugation (300g for 10 mins), red blood cells
were lysed using PharmLyse™ (BD Biosciences, USA) and the
cells stained with a viability dye (fixable Viability Dye-eFluor780,
fixable Viability Dye eFluor 455UV, Fixable Viability Dye eFluorA
B C
FIGURE 1 | Loss of MelLec protects against body weight loss.
(A) Schematic representation of the allergic model used in these experiments.
Wild type (wt) or MelLec-/- mice were sensitized by intratracheal
administration with 1x107 live spores of Aspergillus fumigatus ATCC 13073
on days 0 and 7, and then similarly challenged on days 20, 21, and 22. Mice
were sacrificed on day 23, 24 hrs after the last-challenge and analyzed.
(B) Percentage body weight change over the course of the experimental
model and naïve Wild type (wt) or MelLec-/- mice, as indicated. Pooled values
shown are mean ± SEM of five independent experiments (n>40 mice per
group). (C) Lung fungal burdens of mice on day 23. CFU, colony-forming unit.
Shown are pooled data (with mean) from two independent experiments (n=16
mice). *p<0.05. Statistical significance was determined using t-tests. n.s., not
significant.May 2021 | Volume 12 | Article 675702
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Scientific, USA). Cells were recovered by centrifugation and
resuspended in flow staining buffer (0.5% of bovine serum
albumin, 2mM of EDTA in sterile PBS) with 8mg/mL of anti-
CD16/CD32 (Fc-block, Clone 2.4G2, prepared in house). For
analyzing cellular cytokine expression, lung single cell
suspensions were plated in 6 well plates at 1x106 cells/well and
stimulated with phorbol 12-myristate 13-acetate (PMA) (50 ng/
ml), ionomycin (1mg/ml) (both Sigma) at 37°C for 5 hrs.
Brefeldin A (5 mg/ml) and Monensin (5 mg/ml) (both Merck
KGaA, Germany) were then added, and the cells were incubated
for a further 3 hr. For cell surface staining, antibody cocktails
containing 1:200 antibodies in PBS were added and incubated for
30 mins on ice. The cells were then washed with staining buffer
and analyzed. When required, cells were fixed with 1%
paraformaldehyde. For intracellular staining, cells were
permeabilized using the Foxp3 permeabilization kit (Thermo
Fisher Scientific, USA). The following antibodies were used:
CD11B-BUV395 (M1/70) CD11C-BB700 (HL3), CD44-AF700
(IM7), CD44-BB515 (IM7), CD45-BV650 (30-F11), Foxp3-
AF647 (MF23), GATA-3-BUV395 (L50-823), IFNg-FITC
(XMG1.2), IL-10-PE (JES5-16E3), IL-17-BV605 (TC11-
18H10), IL-4-APC (11B11), Ly6C-FITC (AL-21), Ly6G-PE
(1A8), RORgT-PE (Q31-378), T-bet-BUV421 (O4-46) (all
from BD) and B220-BV605 (RA3-6B2), CD4-AF700 (RM4-5)
(BioLegend, USA). Control samples such as unstained, isotype
and Fluorescence Minus One (FMO) were acquired to find out
the boundary and specificity of the fluorescence signal. Flow
cytometry was performed on BD LSR Fortessa™ (BD
Biosciences, USA) or Attune NxT Flow Cytometer (Thermo
Fisher Scientific, USA) and analyzed with FlowJo 10 software
(BD Biosciences, USA). Gating strategies used are shown in
Supplementary Figures 1 and 2 (8, 9).
Cytokine Assays and Fungal Burdens
Lungs homogenates were used to assay lung cytokines and fungal
burdens. Cytokine levels were analyzed with multiplex bead-
based assays (R&D), according to the manufacturer’s
instructions. Cytokine concentrations were normalized for
protein content (BCA protein assay kit, Thermo Fisher
Scientific). For fungal burdens, serially diluted suspensions of
aseptically prepared lung homogenates were freshly plated onto
potato dextrose agar plates and Colony Forming Units (CFUs)
determined after 36-48hrs incubation at 37°C.
Histology
Lungs were inflated with 50% Optimal Cutting Temperature
(OCT, Tissue-Tek, Sakura, Netherlands) compound in PBS
followed by fixation in 10% formaldehyde and embedded in
paraffin wax. 10mm sections were stained with Haematoxylin and
Eosin (H&E) or Periodic Acid Schiff (PAS, TAAB Laboratories,
UK) using standard methodology. Quantification of
inflammation area, bronchial wall thickening (taking the
average of four cross section measurements of each
bronchiole), and percentage of PAS positive cells were
performed using ZEN2 software (Carl Zeiss) and Image JFrontiers in Immunology | www.frontiersin.org 3software (Centre for Information Technology, National
Institute of Health, Bethesda, Maryland), scoring five
representative bronchioles from at least two different mice.
Comparable bronchioles from wt and MelLec-/- mice were
selected for analysis, selecting proximal areas that were not
adjacent to other bronchioles. Inflammation area and
bronchial wall thickening measurements were standardized to
the outside diameter of the bronchioles.Statistical Analysis
Two-tailed student’s t-tests, Mann–Whitney U tests, or one-way
ANOVA were used to determine statistical significance. All
experiments were independently repeated at least once, unless
otherwise indicated. A p value of < 0.05 was considered to be
statistically significant. Statistical analyses were performed using
Prism (version 7; GraphPad Software, La Jolla, CA, USA).RESULTS
Loss of MelLec Protects Against Body
Weight Loss
To determine if MelLec plays a role in the development of
pulmonary allergic responses, we made use of a standard
mouse model of sensitization and challenge (5, 10) using live
A. fumigatus conidia (Figure 1A). Treatment of wt mice
significantly affected their ability to gain weight, compared to
untreated animals (Figure 1B). In contrast, MelLec-deficient
mice displayed no adverse effects, gaining weight at a rate
comparable to naïve animals (Figure 1B). Moreover, the
knockout animals did not display any clinical symptoms or
succumb to the repeated conidial challenge (data not shown).
The effect on weight gain was not due to any intrinsic difference
in the two groups of animals, as weight gain in naïve mice was
equivalent (Figure 1B), as we reported previously (6). The effect
of this protocol in wt animals required live conidia, as
administration of heat-killed conidia had no effect on weight
gain or inflammation (Supplementary Figures 3A, B).
Remarkably, despite showing no adverse clinical symptoms,
MelLec-/- mice presented with substantially higher pulmonary
fungal burdens (Figure 1C). Fungal burdens were cleared in both
groups of animals 7 days following last challenge. No CFU were
detected in the lung of unchallenged animals (not shown).
MelLec-/- Mice Have Reduced Pulmonary
Inflammation and Bronchial
Wall Thickening
We next performed histological analysis of lungs of wt and
MelLec-/- mice on day 23, following the last challenge with A.
fumigatus conidia (Figure 1A). As expected (5, 10), wt mice
presented with inflammatory foci around bronchioles and
increased bronchial wall thickening (Figures 2A–C). In
contrast, MelLec-deficient mice presented with significantly
less pulmonary inflammation and bronchial wall thickeningMay 2021 | Volume 12 | Article 675702
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inflammatory response in these animals. On the other hand,
using PAS staining, we found no differences between wt and
MelLec-/- mice in mucus-producing goblet cells (Figures 2A, D),
which are induced as part of the allergic response (10).
MelLec Regulates Neutrophil,
Inflammatory Monocyte and T-Cell
Recruitment During A. fumigatus-Induced
Allergic Inflammation
We then analyzed the composition of cellular infiltrate in the
lungs of challenged mice by flow cytometry (Supplementary
Figure 1). Consistent with our histological observations,
described above, we observed significantly reduced numbers of
total viable CD45+ myeloid cells in the lungs of the knock-out
mice compared to wt animals (Figure 3A). This reduced cellular
inflammation correlated with a reduced influx of CD11b+Ly6G+
neutrophils (Figure 3B), CD11b+Ly6Chigh inflammatory
monocytes (Figure 3C) and T-cells (Figure 3D). Notably, wt
and MelLec-/- mice presented with similar numbers of
CD11b+Siglec-F+ eosinophils (Figure 3E), and also had similar
numbers of CD11c+Siglec-F+ alveolar macrophages (Figure 3F).
There were no differences in inflammatory cell numbers in
the lungs of naïve wt and MelLec-/- mice, although theFrontiers in Immunology | www.frontiersin.org 4knockout mice possessed higher basal levels of alveolar
macrophages (Figure 3F).
MelLec Influences Cytokine Responses
During Allergic Inflammation
To gain insight into underlying reasons for the reduced cellular
inflammation in the MelLec-deficient animals, we determined
pulmonary inflammatory cytokine and chemokine responses.
Compared to wt animals, MelLec-deficient mice presented with
significantly lower levels of multiple inflammatory cytokines and
chemokines including TNFa, IL-1b, CCL2, CCL5, CCL11,
CXCL2 and CXCL5 (Figure 4). Data from naïve mice are
shown in Supplementary Figure 4.Loss of MelLec Leads to Reduced
Th17 Responses
Finally, using flow cytometry (Supplementary Figure 2), we
determined if loss of MelLec influenced the development of
pulmonary CD4+ T-cell responses in our allergic model. In
comparison to wt mice, we observed no alterations in the levels of
expression of GATA3 and FoxP3 in activated T-cells from MelLec-
deficient animals, indicating that similar Th2 and Treg responses
were being induced similarly in both groups (Figure 5A). In
contrast, there were significantly fewer RORgT+ T-cells in the
knockout animals. There was no significant induction of T-bet in
wt or MelLec-deficient mice, in this model (Figure 5A). Analysis ofA B
D E F
C
FIGURE 3 | Loss of MelLec leads to reduced pulmonary cellular
inflammation. (A) Total CD45+ leukocytes, (B) neutrophils (Ly6G+CD11b+),
(C) inflammatory macrophage/monocytes (Ly6c+CD11b+), (D) total T-cells
(CD11b-CD11c-MHCII-), (E) eosinophils (SIGLEC-F+CD11b+) and (F) alveolar
macrophages (SIGLEC-F+CD11c+) in the lungs of wild type (wt) and MelLec-/-
mice, as indicated, on day 23 following allergic sensitization and challenge
with live Aspergillus fumigatus conidia. Cellular counts from naïve mice are
also shown (n=4). See Supplementary Figure 1 for gating strategy). Shown
are pooled data (with mean) from at least two independent experiments (n>20
mice). *p<0.05. n.s., not significant. Statistical significance was determined
using ANOVA.A
B DC
FIGURE 2 | MelLec-deficient mice have reduced pulmonary pathology.
(A) Representative Haematoxylin and Eosin (H&E) (top panels) and Periodic
Acid Schiff (PAS) (bottom panels) stained lung sections from wild type (wt)
and MelLec-/- mice, as indicated, on day 23 following allergic sensitization and
challenge with live Aspergillus fumigatus conidia. Scale bars represent 100
mm. Histological quantification of bronchial (B) inflammation (n=3; WT means
8644, 11892 and 7880 mm2; KO means 7104, 6176, 4081 mm2; mean
difference is n.s.), (C) wall thickness (n=3; WT means 7.0, 7.4 and 6.1mm; KO
means 5.2, 3.5, 4.0 mm; mean difference p<0.05) and (D) goblet cell
hyperplasia (n=2; WT means 53.1 and 78.4%; KO means 74.5 and 66.9%),
versus naïve mice (n=2). Shown are pooled data (with mean) of five
representative bronchioles from the indicated number of mice. *p<0.05, n.s.,
not significant, determined from pooling the data of all samples from the mice.
Statistical significance was determined using ANOVA (B, C) and student
t-test (D).May 2021 | Volume 12 | Article 675702
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cells were reduced (Figure 5B), although the difference was not
statistically significant (p=0.053). Activated IL4+ and IFNg+
producing T-cells were similarly induced in both wt and MelLec-
deficient mice. We did not detect significant induction of IL-10+
-producing T-cells in either group of mice, compared to naïve
animals (Figure 5B).Frontiers in Immunology | www.frontiersin.org 5DISCUSSION
Asthma is a common lung disease characterized by chronic airway
inflammation. Genetics and environmental factors are related to
pathogenesis, with major environmental risk factors including
inhaled substances and particles (such as fungi) that provoke
allergic reactions (11). While the link between fungal sensitizationA
B
FIGURE 5 | Altered T-cell responses in MelLec-deficient mice. Flow cytometric analysis of T-cell expressed (A) transcription factors and (B) cytokines, as indicated, in
the lungs of wild type (wt) and MelLec-/- mice on day 23 following sensitization and challenge with live Aspergillus fumigatus conidia. CD44+CD4+ T cells expressing
transcription factors or cytokines are expressed as numbers per 1x105 CD45+ cells. Shown are pooled data (with mean) from at least two independent experiments
(n>15 mice). Data from unchallenged naïve mice are also shown (n=3). *p<0.05. n.s., not significant. Statistical significance was determined using ANOVA.FIGURE 4 | Loss of MelLec leads to reduced pulmonary cytokine and chemokine levels. Cytokine and chemokine levels in the lungs of wild type (wt) and MelLec-/-
mice on day 23 following sensitization and challenge with live Aspergillus fumigatus conidia. Shown are pooled data (with mean) from at least two independent
experiments (n>15 mice). *p<0.05. Statistical significance between wt and MelLec-/- animals were determined using t-tests. Data from naïve mice are shown in
Supplementary Figure 4.May 2021 | Volume 12 | Article 675702
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which fungi influence pulmonary allergic responses are still unclear.
Several studies have linked the development of allergic responses to
fungal cell wall components such as b-glucan or mannan, which
induce immune responses through receptors including CLRs such
as Dectin-1 (3). Many fungal pathogens linked to asthma, such as
Aspergillus spp., Alternaria spp., or Cladosporium spp. also produce
DHN-melanin, which has been suggested to modulate pulmonary
inflammation in mouse models of asthma (12). In fungi, melanin
has been implicated in diverse functions, including radiation
protection, immune defense, and virulence (13).
We recently identified a novel CLR, MelLec, which recognizes
fungal DHN-melanin and was essential for resistance to systemic
infection with A. fumigatus (6). Loss of MelLec led to increased
fungal burdens and alterations in inflammatory responses, from
which the animals succumbed (6). In that study, we also showed
that MelLec-deficient mice challenged with a single intratracheal
dose of A. fumigatus conidia presented with reduced pulmonary
inflammatory responses at 4hr following challenge (6), although
the inflammation reverted to the levels found in the wt mice by
24hr (6). Notably, loss of MelLec did not alter the susceptibility
of mice to pulmonary infection (6).
Given that A. fumigatus is thought to be one of the most
important fungal organisms involved in the pathogenesis of
asthma (1), we explored how MelLec influenced the development
of pulmonary allergic responses with this pathogen in a mouse
model. Unexpectedly, we found that MelLec-deficiency was
protective. In contrast to wt animals, MelLec-/- mice showed no
adverse effects on weight gain. In fact, these animals gained weight
at a rate equivalent to uninfected knockout or wt animals. There
were also no alterations in the ability of MelLec-deficient mice to
survive infection following repeated administration of conidia,
similar to what we had observed following a single challenge (6).
Thus, MelLec appears to be dispensable for resistance to pulmonary
infection with A. fumigatus in immunocompetent animals, even
after repeated challenges.
The protective effect of MelLec-deficiency is likely to be due to
the significantly reduced pulmonary inflammatory responses in
these animals. Indeed, loss of MelLec was associated with reduced
cellular influx into the lungs, particularly neutrophils and
inflammatory monocytes, and correlated with reduced levels of
multiple inflammatory cytokine and chemokines. The impact on
neutrophil recruitment is consistent with our previous observations
following a single pulmonary challenge with conidia (6). Moreover,
our data are also consistent with a previous report demonstrating
reduced pulmonary neutrophil responses in wild type mice
challenged with A. fumigatus Dalb1, which lack melanin,
compared to wild type mice challenged with melanized conidia
(12). This reduced cellular inflammation also correlated with our
histological analysis. However, we note that the difference in
pulmonary inflammation, as determined by histology, was only
apparent when we pooled measurements of each individual
bronchiole from the animals sampled. There was no significant
difference in inflammation by histology, when the means of each
animal were compared, indicating that the study was
underpowered. Nevertheless, the cumulative evidence from theFrontiers in Immunology | www.frontiersin.org 6flow cytometry analyses of cellular influx, the cytokine analyses,
and histological assessments indicate that MelLec-/- mice have
reduced pulmonary inflammation in this allergic model.
Surprisingly, knockout animals had ~0.5 log higher fungal lung
burdens compared to wt animals, yet displayed no obvious adverse
clinical effects. This indicates that although MelLec is required to
control fungal burden in the lungs, as we have noted previously
(6), the inflammatory responses mediated by the receptor in this
allergic model negatively impact welfare of the animals.
Interestingly, in a immunocompromised (cyclophosphamide)
mouse model of pulmonary infection with a single dose (106) of
A. fumigatus conidia, there was also a reproducible, but non-
significant, trend towards increased survival and higher fungal
burdens in the MelLec-/- animals (Stappers et al., personal
communication). Such increased fungal burdens are likely to
have a physiological impact that has yet to be revealed.
The alterations in neutrophil recruitment suggested that MelLec
may influence the development of Th17 immunity. Th17 responses
are associated with asthma pathogenesis, especially in corticosteroid
resistant refractory asthma where neutrophils play a critical role
(14). Moreover, the use of inhaled corticosteroids can lead to
increased fungal burdens and deterioration of asthma control
(15). We found a significant reduction in the number of activated
Th17 cells (CD44+RORgt+) in the lungs of MelLec-deficient
animals, suggesting that this CLR promotes the development of
Th17 immunity. This correlated with a reduced number of
CD44+IL17+ T-cells in MelLec-deficient animals, although this
result was not statistically significant (p=0.053). Th2 responses
were largely unaffected in the MelLec-/- mice, evidenced by
equivalent eosinophil recruitment, equivalent goblet cell
hyperplasia, and equivalent Th2 T-cells in the lungs of these
animals. The induction of Th1 and Treg responses appeared
unaffected by MelLec deficiency. Our data is in contrast to a
previous report that suggested that MelLec functions to suppress
Th17 and Th1 responses, but this difference is likely due the
different (non-pulmonary) experimental immunization protocol
and the different rodent species used in that study (7).
How MelLec mediates its functions are still unclear. The
cytoplasmic tail of MelLec lacks recognizable signaling motifs (6),
and the receptor is primarily expressed by endothelial cells in mice.
Although endothelial cells do contribute to asthma pathogenesis
(16), it is still unclear howMelLec is able to sense fungal melanin in
the endothelium following airway administration of conidia. One
possibility could be the shedding of melanin, once the conidia begin
to swell and germinate (17). Moreover, while other pattern
recognition receptors, such as protease-activated receptor 2 (PAR-
2), play an active role in mediating endothelial-mediated allergic
responses (16), it is unclear how MelLec functions in this context.
MelLec is likely to contribute to the pathogenesis of asthma in
humans, as we have shown that the human receptor recognizes
DHN-melanin and plays a role in anti-Aspergillus immunity (6).
Notably, we discovered a common polymorphism of this receptor
that increases susceptibility to systemic infections with Aspergillus,
in part through reduced inflammatory responses (6). It is tempting
to speculate that the alterations in MelLec function associated with
this polymorphism (6), may protect against allergic pulmonaryMay 2021 | Volume 12 | Article 675702
Tone et al. MelLec Regulates Asthma Pathogenesisresponses to melanized fungi in humans as we have seen in our
mouse model. How MelLec mediates its activities and its
contribution to the pathogenesis of human asthma is the focus of
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